Content related to Rare Insight: A New Approach Optimizes Hepatoblastoma Cancer Treatment

A new study reveals the value of using clinical and histological characteristics to optimize treatment for hepatoblastoma, a rare liver cancer in children.

Program combines clinical expertise and basic science to advance care in an understudied cancer.

Researchers have been delving deeper to better understand long-term cancer survival and quality of life for adolescent and young adult patients.

5 Questions for Jeri Wilson, Executive Director of the Pediatric Cancer Research Foundation

A recent study found that the growth factor G-CSF, used in high-risk neuroblastoma treatment, leads to increased tumor growth and metastasis. Investigators think the benefits still outweigh the risks.